Jacqueline (Xiao) Chen
About Jacqueline (Xiao) Chen
Jacqueline (Xiao) Chen is the Head of Strategic Entities and Corporate Development Lead at MassMutual in Boston, Massachusetts.
Current Role at MassMutual
Jacqueline (Xiao) Chen currently serves as the Head of Strategic Entities and Corporate Development Lead at MassMutual in Boston, Massachusetts. She also leads the Strategy, Corporate Development, Consumer, and Market Insights team. Since joining MassMutual in 2018, she has been a key figure in transactions exceeding $15 billion, including significant deals like the acquisition of Rothesay Life and the sale of MassMutual Japan to Nippon Life.
Professional Experience at Mirae Asset Global Investments
From 2015 to 2018, Jacqueline worked at Mirae Asset Global Investments as Principal Investment and Corporate Development. During her tenure, she was instrumental in expanding the company’s U.S. and global footprint through both inorganic and organic growth strategies. Her role involved identifying key opportunities and implementing strategic initiatives to foster the company's expansion.
Investment Banking Career
Jacqueline’s career in investment banking includes positions at MUFG, Brevet Capital Management, and UBS Investment Bank. At MUFG, she specialized in M&A financing and cross-border transactions from 2014 to 2015. Prior to that, she was a direct lending and special situation investor at Brevet Capital Management from 2013 to 2014. Her career began at UBS Investment Bank in 2011, where she covered financial institutions sectors, including insurance, asset management, FinTech, and specialty finance.
Educational Background
Jacqueline earned a Bachelor of Science (BS) in Economics from Duke University. She also studied Advanced Piano Performance at The Juilliard School. This unique combination of analytical skills and artistic training has contributed to her multifaceted approach to corporate development and strategic initiatives.
Key Transactions and Achievements
Throughout her career, Jacqueline has played key roles in high-profile transactions. At MassMutual, she was involved in the sale of OppenheimerFunds to Invesco and the sale of MassMutual Asia to a consortium including Ant Financial. Her strategic input has been crucial in aligning key interests and maximizing value for MassMutual through frequent business relationship touch-points and robust M&A opportunities.